Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Talis Biomedical Corporation Common Stock (TLIS)

Laboratory Analytical Instruments

https://talisbio.com

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.

1100 ISLAND DRIVE, SUITE 101
REDWOOD CITY, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/12/2021

Market Cap

7,616,587

Shares Outstanding

1,820,000

Weighted SO

1,821,128

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.6800

Last Div

0.0000

Range

3.75-9.6

Chg

0.0400

Avg Vol

15916

Mkt Cap

7616587

Exch

NASDAQ

Country

US

Phone

650 433 3000

DCF Diff

8.7195

DCF

0.0306

Div Yield

0.0000

P/S

21.8867

EV Multiple

0.7799

P/FV

0.1344

Div Yield %

0.0000

P/E

-0.1331

PEG

-0.0029

Payout

0.0000

Current Ratio

7.5145

Quick Ratio

7.5145

Cash Ratio

7.4266

DSO

6.2931

DIO

0.0000

Op Cycle

6.2931

DPO

1462.8295

CCC

-1456.5364

Gross Margin

-1.5948

Op Margin

-163.8161

Pretax Margin

-164.3994

Net Margin

-164.3994

Eff Tax Rate

-0.0295

ROA

-0.6935

ROE

-0.7540

ROCE

-0.7807

NI/EBT

1.0000

EBT/EBIT

1.0036

EBIT/Rev

-163.8161

Debt Ratio

0.2332

D/E

0.3394

LT Debt/Cap

0.2238

Total Debt/Cap

0.2534

Int Coverage

-48.8919

CF/Debt

-2.2453

Equity Multi

1.4553

Rec Turnover

58.0000

Pay Turnover

0.2495

Inv Turnover

0.0000

FA Turnover

0.0356

Asset Turnover

0.0042

OCF/Share

-23.7107

FCF/Share

-23.9642

Cash/Share

38.6032

OCF/Sales

-124.1437

FCF/OCF

1.0107

CF Coverage

-2.2453

ST Coverage

-14.8870

CapEx Coverage

-93.5108

Div&CapEx Cov

-93.5108

P/BV

0.1344

P/B

0.1344

P/S

21.8867

P/E

-0.1331

P/FCF

-0.1744

P/OCF

-0.1763

P/CF

-0.1763

PEG

-0.0029

P/S

21.8867

EV Multiple

0.7799

P/FV

0.1344

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation